Skip to content

Pediatrix Medical Group MD Accounts payable and other current liabilities (Note 11)

Accounts payable and other current liabilities (Note 11) at other companies

Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×
P/S+0.3×

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's accounts payable and other current liabilities (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's accounts payable and other current liabilities (note 11)?
Pediatrix Medical Group (MD) reported accounts payable and other current liabilities (note 11) of $236.93M in Q1 2026.
How has Pediatrix Medical Group's accounts payable and other current liabilities (note 11) changed year-over-year?
Pediatrix Medical Group's accounts payable and other current liabilities (note 11) increased by 1.2% year-over-year, from $234.17M to $236.93M.
What is the long-term trend for Pediatrix Medical Group's accounts payable and other current liabilities (note 11)?
Over 5 years (2020 to 2025), Pediatrix Medical Group's accounts payable and other current liabilities (note 11) has grown at a -0.2% compound annual growth rate (CAGR), from $423.18M to $419.53M.